Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: A pilot study

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 9, 2009, Pages 1185-1195

  Valladares Ayerbes, Manuel ^a   Iglesias Díaz, Pilar ^a   Díaz Prado, Silvia ^a,b   Ayude, Daniel ^b,c   Medina, Vanessa ^b   Haz, Mar ^b   Reboredo, Margarita ^a   Antolín, Silvia ^a   Calvo, Lourdes ^a   Antón Aparicio, Luis M ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b Biomedical Research Institute INIBIC   (Spain)

^c La Coruña University ^*  (Spain)

Author keywords

Breast tumour cells; Isolated tumour cells; Minimal disease; RNA based methods; Small breast epithelial mucin

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN AE1 ANTIBODY; CYTOKERATIN AE3 ANTIBODY; CYTOKERATIN ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; MESSENGER RNA; MUCIN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; BONE MARROW; BONE MARROW METASTASIS; BONE MARROW MICROMETASTASIS; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CANCER PATIENT; CELL HETEROGENEITY; CLINICAL ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KAPLAN MEIER METHOD; PARAMETER; PATHOLOGY; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUCINS; NEOPLASM STAGING; PILOT PROJECTS; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 68649115260     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0559-7     Document Type: Article

References (42)

1. AceView: a comprehensive cDNA-supported gene and transcripts annotation. http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/av.cgi?exdb=AceView&db= 36a&term=SBEM&submit=Go
2. M Allinen R Beroukhim L Cai 2004 Molecular characterization of the tumour microenvironment in breast cancer Cancer Cell 6 17 32 10.1016/j.ccr.2004.06.010 (Pubitemid 38903159)
3. MV Ayerbes S Díaz-Prado D Ayude 2008 In silico and in vitro analysis of small breast epithelial mucin as a marker for bone marrow micrometastasis in breast cancer Adv Exp Med Biol 617 331 339 10.1007/978-0-387-69080-3-31
4. IH Benoy H Elst I Van der Auwera 2004 Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer Br J Cancer 91 1813 1820 10.1038/sj.bjc.6602189 (Pubitemid 39664970)
5. FC Bidard A Vincent-Salomon S Gomme 2008 Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse Clin Cancer Res 14 3306 3311 10.1158/1078-0432.CCR-07-4749
6. FC Bidard A Vincent-Salomon B Sigal-Zafrani 2008 Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells Ann Oncol 19 496 500 10.1093/annonc/mdm507 (Pubitemid 351325670)
7. Borgen E, Naume B, Nesland et al (1999) Standardisation of the immunocytochemical detection of cancer cells inbone marrow and blood. I. Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1:377-388. doi: 10.1080/0032472031000141283
8. S Braun B Naume 2005 Circulating and disseminated tumour cells. Review Article J Clin Oncol 23 1623 1626 10.1200/JCO.2005.10.073 (Pubitemid 46211415)
9. S Braun K Pantel P Müller 2000 Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer N Engl J Med 342 525 533 10.1056/NEJM200002243420801 (Pubitemid 30117892)
10. S Braun F Vogl B Naume 2005 A pooled analysis of bone marrow micrometastasis in breast cancer N Engl J Med 353 793 802 10.1056/NEJMoa050434 (Pubitemid 41215488)
11. NM Brown TT Stenzel PN Friedman J Henslee G Huper JR Marks 2006 Evaluation of expression based markers for the detection of breast cancer cells Breast Cancer Res Treat 97 41 47 10.1007/s10549-005-9085-8 (Pubitemid 43750947)
12. V Choesmel JY Pierga C Nos A Vincent-Salomon B Sigal-Zafrani JP Thiery N Blin 2004 Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance Breast Cancer Res 6 R556 R569 10.1186/bcr898
13. TL Colpitts P Billing E Granados 2002 Identification and immunohistochemical characterization of a mucin-like glycoprotein expressed in early stage breast carcinoma Tumour Biol 23 263 278 10.1159/000068566 (Pubitemid 36302484)
14. J Ferlay P Autier M Boniol M Heanue M Colombet P Boyle 2007 Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 581 592 10.1093/annonc/mdl498 (Pubitemid 46359643)
15. R Gangnus S Langer E Breit K Pantel MR Speicher 2004 Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients Clin Cancer Res 10 3457 3464 10.1158/1078-0432.CCR-03-0818 (Pubitemid 38685453)
16. RL Houghton DC Dillon DA Molesh 2001 Transcriptional complementarity in breast cancer: application to detection of circulating tumour cells Mol Diagn 6 79 91 10.2165/00066982-200106020-00003
17. M Ignatiadis N Xenidis M Perraki 2007 Different prognostic value of cytokeratin-19 mRNA positive circulating tumour cells according to estrogen receptor and HER2 status in early-stage breast cancer J Clin Oncol 25 5194 5202 10.1200/JCO.2007.11.7762 (Pubitemid 350232250)
18. W Janni S Gastroph F Hepp 2000 Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma Cancer 88 2252 2259 10.1002/(SICI)1097- 0142(20000515)88:10<2252::AID-CNCR8>3.0.CO;2-Q (Pubitemid 30247124)
19. CA Klein TJF Blankenstein O Schmidt-Kittler 2002 Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer Lancet 360 683 689 10.1016/S0140-6736(02)09838-0 (Pubitemid 35232337)
20. WH Kruger R Jung B Detlefsen 2001 Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells Med Oncol 18 33 38 10.1385/MO:18:1:33 (Pubitemid 32906734)
21. M Lacroix 2006 Significance, detection and markers of disseminated breast cancer cells Endocr Relat Cancer 13 1033 1067 10.1677/ERC-06-0001 (Pubitemid 46212562)
22. M Lacroix G Leclercq 2004 Relevance of breast cancer cell lines as models for breast tumours: an update Breast Cancer Res Treat 83 249 289 10.1023/B:BREA.0000014042.54925.cc (Pubitemid 38264873)
23. AC Lambrechts AJ Bosma SG Klaver B Top L Perebolte LJ van't Veer S Rodenhuis 1999 Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells Breast Cancer Res Treat 56 219 231 10.1023/A:1006261731125
24. X-J Ma R Salunga JT Tuggle 2003 Gene expression profiles of human breast cancer progression Proc Natl Acad Sci USA 100 5974 5979 10.1073/pnas.0931261100 (Pubitemid 36576916)
25. RJ Miksicek Y Myal PH Watson C Walker LC Murphy E Leygue 2002 Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumour human mammary epithelium Cancer Res 62 2736 2740
26. V Muller N Stahmann S Riethdorf 2005 Circulating tumour cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity Clin Cancer Res 11 3678 3685 10.1158/1078-0432.CCR-04-2469 (Pubitemid 40685584)
27. B Naume X Zhao M Synnestvedt 2007 Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer Mol Oncol 1 160 171 10.1016/j.molonc.2007.03.004 (Pubitemid 47199130)
28. K Pantel C Alix-Panabieres 2007 The clinical significance of circulating tumour cells Nat Clin Pract Oncol 4 62 63 10.1038/ncponc0737 (Pubitemid 46189529)
29. K Pantel G Schlimok S Braun 1993 Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells J Natl Cancer Inst 85 1419 1424 10.1093/jnci/85.17.1419
30. K Pantel G Schlimok M Angstwurm 1994 Methodological analysis of immunocytochemical screening for disseminated epithelial tumour cells in bone marrow J Hematother 3 165 173
31. AE Ring L Zabaglo MG Ormerod IE Smith M Dowsett 2005 Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques Br J Cancer 92 906 912 10.1038/sj.bjc.6602418 (Pubitemid 40462638)
32. S Rozen HJ Skaletsky 2000
33. C Schindlbeck T Kampik W Janni 2005 Prognostic relevance of disseminated tumour cells in the bone marrow and biological factors of 265 primary breast carcinomas Breast Cancer Res 7 R1174 R1185 10.1186/bcr1360
34. A Schoenfeld KH Kruger J Gomm 1997 The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19 Eur J Cancer 33 854 861 10.1016/S0959-8049(97)00014-2 (Pubitemid 27287035)
35. GP Skliris F Hube' I Gheorghiu 2008 Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers Histopathology 52 355 369 10.1111/j.1365-2559.2007.02955.x (Pubitemid 351208066)
36. MJ Slade BM Smith HD Sinnett NC Cross RC Coombes 1999 Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer J Clin Oncol 17 870 879
37. I Soerjomataram MW Louwman JG Ribot JA Roukema JWW Coebergh 2008 An overview of prognostic factors for long-term survivors of breast cancer Breast Cancer Res Treat 107 309 330 10.1007/s10549-007-9556-1 (Pubitemid 351172108)
38. A Verdecchia S Francisci H Brenner 2007 Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data Lancet Oncol 8 784 796 10.1016/S1470-2045(07)70246-2 (Pubitemid 47321601)
39. MA Watson LA Ylagan KM Trinkaus 2007 Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumour relapse in breast cancer patients Clin Cancer Res 13 5001 5009 10.1158/1078-0432.CCR-07-0024 (Pubitemid 47502064)
40. G Wiedswang E Borgen R Karesen 2003 Detection of isolated tumour cells in bone marrow is an independent prognostic factor in breast cancer J Clin Oncol 21 3469 3478 10.1200/JCO.2003.02.009 (Pubitemid 46594079)
41. B Willipinski-Stapelfeldt S Riethdorf V Assmann 2005 Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells Clin Cancer Res 11 8006 8014 10.1158/1078-0432.CCR-05-0632 (Pubitemid 41698741)
42. U Woelfle J Cloos G Sauter 2003 Molecular signature associated with bone marrow micrometastasis in human breast cancer Cancer Res 63 5679 5684